Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Roche
Most Recent Events
- 09 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 May 2015 Planned End Date changed from 1 Nov 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 14 May 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.